Cornercap Investment Counsel Inc Fulgent Genetics, Inc. Transaction History

Cornercap Investment Counsel Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$59.3 - $183.85 $4.38 Million - $13.6 Million	-73,901 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $2.29 Million - $3.85 Million	73,901 New	73,901 $953,000
Q2 2020 Aug 13, 2020	SELL	$8.89 - $18.28 $530,199 - $1.09 Million	-59,640 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$6.75 - $19.75 $166,529 - $487,252	-24,671 Reduced 29.26%	59,640 $642,000
Q4 2019 Feb 14, 2020	BUY	$9.29 - $15.82 $783,249 - $1.33 Million	84,311 New	84,311 $1.09 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.